Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800cw

HIGHLIGHTS

  • who: Lydian A. Huisman from the CEAUniversity of have published the Article: Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW, in the Journal: Scientific Reports Scientific Reports of 20/05/2020
  • what: In this study, the feasibility of bevacizumab-800CWbased optical imaging for the detection of carotid plaque instability was assessed. The aim of this study was to determine whether the optical tracer bevacizumab-800CW is suitable for ex vivo visualization of intraplaque angiogenesis by means of identifying VEGF-A presence, and thereby able to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?